Edison Research: Nanoco Group PLC – Building foundations for volume uptake in FY20

FY18 results were as expected, with revenues up and losses narrowed despite the slow commercialisation cycle in display. FY19 will be a year of laying foundations to ready the facilities for volume production in nanomaterials, but we expect a doubling of revenues nonetheless. The move to volume production should support a further inflection in FY20.

Growth in revenues to £3.3m (vs £1.3m in FY17) reflects the contribution from the company’s tier one US customer. Adjusted operating loss dropped to £7.2m from £10.7m in 2017, with the higher revenues supported by the full-year benefit of FY17 cost savings. Year-end net cash of £10.7m (our forecast £7.9m) reflects the fact that billings increased to £6.5m from £1.1m, including £3.1m of deferred income; we had previously categorised some of this as a loan.

 

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical